Clinical Trial Update: CES1 Carriers in the PAPI Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update focusing on CES1 carrier status in the PAPI study; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Artery Occlusion
• Cardiovascular Diseases
• Coronary Artery Disease
• Coronary Disease
• Heart Diseases
• Myocardial Ischemia

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Heart Diseases, Coronary Disease | Phase 4 | Status: COMPLETED | Results posted: 2023-06-15